Analytical & Technical Leadership

From early-phase feasibility to final design requirements and commercialization, we confidently meet the needs of challenging drug formulations.

  • Rapid feasibility and early-phase development capabilities
  • Human tolerability and human factors studies
  • Proven ability to develop challenging drug formulations
  • Preclinical and clinical capabilities
  • Regulatory leadership and expert data analysis to support submissions and filings

Innovative Devices

Our intradermal drug-delivery platforms are designed for accurate dosing and reliable microneedle-based delivery for commercial applications of biologics and small molecules. Whether your molecule is liquid or solid, we can deliver it in a combination product customized for your patients and brand.

  • Solid Intradermal Drug Delivery Platform – solid-coated microneedle array offer potential for increased immunogenicity, dose sparing, cold-chain elimination, and increased patient convenience via self-administration
  • Liquid Intradermal Drug Delivery Platform – offers reproducible intradermal delivery of liquid formulations across a wide range of viscosities, volumes, and delivery durations, through an array of hollow microneedles

Operational Excellence

With sophisticated project management, rigorous quality processes, manufacturing excellence, and cGMP facilities, Kindeva supports a reliable supply chain for your program.

  • Automated array molding and packaging
  • Aseptic array coating for solid microneedles
  • Qualified equipment for device-assembly process
  • Manufacturing capability for preclinical, clinical, and scale-up activities

A history of launching next-generation drug delivery systems

Learn more